IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 394 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $465,666 | +21.7% | 10,266 | +10.1% | 0.00% | 0.0% |
Q2 2023 | $382,687 | +13.2% | 9,327 | -1.4% | 0.00% | +100.0% |
Q1 2023 | $338,029 | -6.1% | 9,458 | -0.7% | 0.00% | -50.0% |
Q4 2022 | $359,873 | +579.0% | 9,528 | +566.8% | 0.00% | – |
Q2 2022 | $53,000 | +20.5% | 1,429 | +21.1% | 0.00% | – |
Q1 2022 | $44,000 | +10.0% | 1,180 | -9.3% | 0.00% | – |
Q4 2021 | $40,000 | -51.8% | 1,301 | -47.4% | 0.00% | -100.0% |
Q3 2021 | $83,000 | +9.2% | 2,472 | +30.4% | 0.00% | 0.0% |
Q2 2021 | $76,000 | -14.6% | 1,896 | -3.9% | 0.00% | 0.0% |
Q1 2021 | $89,000 | +1.1% | 1,973 | +27.0% | 0.00% | 0.0% |
Q4 2020 | $88,000 | +18.9% | 1,553 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $74,000 | -20.4% | 1,553 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $93,000 | +36.8% | 1,553 | +7.2% | 0.00% | +100.0% |
Q1 2020 | $68,000 | +126.7% | 1,449 | +192.1% | 0.00% | 0.0% |
Q3 2019 | $30,000 | +130.8% | 496 | +153.1% | 0.00% | – |
Q2 2019 | $13,000 | +333.3% | 196 | +366.7% | 0.00% | – |
Q1 2019 | $3,000 | -40.0% | 42 | -51.2% | 0.00% | – |
Q4 2018 | $5,000 | +25.0% | 86 | 0.0% | 0.00% | – |
Q3 2018 | $4,000 | 0.0% | 86 | 0.0% | 0.00% | – |
Q2 2018 | $4,000 | 0.0% | 86 | 0.0% | 0.00% | – |
Q4 2017 | $4,000 | 0.0% | 86 | 0.0% | 0.00% | – |
Q3 2017 | $4,000 | – | 86 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |